Evidence map›Paper›PMID 30190006›Full record

ArticleJournal of the American College of Cardiology2018

Epigenetics: Is the Mode of Conception a Marker for Future Cardiovascular Risk?

Larry A Weinrauch, Marie D Gerhard-Herman, Michael M Mendelson

Abstract readEditorialComment
In one paragraph

Article in Journal of the American College of Cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Larry A WeinrauchKidney and Hypertension Section, E.P. Joslin Research Laboratory, Joslin Diabetes Center, Mount Auburn Hospital, Cambridge, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: lweinrauch@hms.harvard.edu.
Marie D Gerhard-HermanDepartment of Medicine, Cardiovascular Medicine Division, Vascular Medicine Section, Brigham and Women's Hospital, Boston, Massachusetts.
Michael M MendelsonPreventive Cardiology Program, Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.

Funding

Circulating Epigenetic Biomarkers for Personalized Cardiovascular Disease PreventionK99HL136875 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI MENDELSON, MICHAEL MAXWELL · 2017 to 2018
$330k
NHLBI NIH HHS K99 HL136875
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiovascular DiseasesHypertensionAdolescentFertilizationHumansReproductive Techniques, AssistedRisk Factorsassisted reproductionepigeneticshypertensionin vitro fertilizationvascular aging

Identifiers

PMID30190006
PMCPMC6357777

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.